Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 87

1.

Regulators of adult neurogenesis in the healthy and diseased brain.

Grote HE, Hannan AJ.

Clin Exp Pharmacol Physiol. 2007 May-Jun;34(5-6):533-45. Review.

PMID:
17439429
[PubMed - indexed for MEDLINE]
2.

The endocannabinoid system and neurogenesis in health and disease.

Galve-Roperh I, Aguado T, Palazuelos J, Guzmán M.

Neuroscientist. 2007 Apr;13(2):109-14. Review.

PMID:
17404371
[PubMed - indexed for MEDLINE]
3.

Cannabinoid CB1 and CB2 receptors and fatty acid amide hydrolase are specific markers of plaque cell subtypes in human multiple sclerosis.

Benito C, Romero JP, Tolón RM, Clemente D, Docagne F, Hillard CJ, Guaza C, Romero J.

J Neurosci. 2007 Feb 28;27(9):2396-402.

PMID:
17329437
[PubMed - indexed for MEDLINE]
Free Article
4.

A beta oligomers - a decade of discovery.

Walsh DM, Selkoe DJ.

J Neurochem. 2007 Jun;101(5):1172-84. Epub 2007 Feb 5. Review.

PMID:
17286590
[PubMed - indexed for MEDLINE]
5.

Memantine in the treatment of mild-to-moderate Alzheimer's disease.

Cosman KM, Boyle LL, Porsteinsson AP.

Expert Opin Pharmacother. 2007 Feb;8(2):203-14. Review.

PMID:
17257090
[PubMed - indexed for MEDLINE]
6.

Excitotoxicity in a chronic model of multiple sclerosis: Neuroprotective effects of cannabinoids through CB1 and CB2 receptor activation.

Docagne F, Muñetón V, Clemente D, Ali C, Loría F, Correa F, Hernangómez M, Mestre L, Vivien D, Guaza C.

Mol Cell Neurosci. 2007 Apr;34(4):551-61. Epub 2007 Jan 16.

PMID:
17229577
[PubMed - indexed for MEDLINE]
7.

Inflammatory processes in Alzheimer's disease.

Heneka MT, O'Banion MK.

J Neuroimmunol. 2007 Mar;184(1-2):69-91. Epub 2007 Jan 12. Review.

PMID:
17222916
[PubMed - indexed for MEDLINE]
8.

Control of spasticity in a multiple sclerosis model is mediated by CB1, not CB2, cannabinoid receptors.

Pryce G, Baker D.

Br J Pharmacol. 2007 Feb;150(4):519-25. Epub 2007 Jan 15.

PMID:
17220914
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson's disease: importance of antioxidant and cannabinoid receptor-independent properties.

García-Arencibia M, González S, de Lago E, Ramos JA, Mechoulam R, Fernández-Ruiz J.

Brain Res. 2007 Feb 23;1134(1):162-70. Epub 2006 Dec 28.

PMID:
17196181
[PubMed - indexed for MEDLINE]
10.

The role of tau phosphorylation in the pathogenesis of Alzheimer's disease.

Mi K, Johnson GV.

Curr Alzheimer Res. 2006 Dec;3(5):449-63. Review.

PMID:
17168644
[PubMed - indexed for MEDLINE]
11.

The non-psychoactive cannabis constituent cannabidiol is an orally effective therapeutic agent in rat chronic inflammatory and neuropathic pain.

Costa B, Trovato AE, Comelli F, Giagnoni G, Colleoni M.

Eur J Pharmacol. 2007 Feb 5;556(1-3):75-83. Epub 2006 Nov 10.

PMID:
17157290
[PubMed - indexed for MEDLINE]
12.

Cannabinoid CB2 receptor: a new target for controlling neural cell survival?

Fernández-Ruiz J, Romero J, Velasco G, Tolón RM, Ramos JA, Guzmán M.

Trends Pharmacol Sci. 2007 Jan;28(1):39-45. Epub 2006 Dec 1. Review.

PMID:
17141334
[PubMed - indexed for MEDLINE]
13.

A molecular link between the active component of marijuana and Alzheimer's disease pathology.

Eubanks LM, Rogers CJ, Beuscher AE 4th, Koob GF, Olson AJ, Dickerson TJ, Janda KD.

Mol Pharm. 2006 Nov-Dec;3(6):773-7.

PMID:
17140265
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

The microglial NADPH oxidase complex as a source of oxidative stress in Alzheimer's disease.

Wilkinson BL, Landreth GE.

J Neuroinflammation. 2006 Nov 9;3:30.

PMID:
17094809
[PubMed]
Free PMC Article
15.

Non-psychoactive CB2 cannabinoid agonists stimulate neural progenitor proliferation.

Palazuelos J, Aguado T, Egia A, Mechoulam R, Guzmán M, Galve-Roperh I.

FASEB J. 2006 Nov;20(13):2405-7. Epub 2006 Oct 2.

PMID:
17015409
[PubMed - indexed for MEDLINE]
Free Article
16.
17.

Combined cannabinoid therapy via an oromucosal spray.

Perez J.

Drugs Today (Barc). 2006 Aug;42(8):495-503. Review.

PMID:
16969427
[PubMed - indexed for MEDLINE]
18.

Inflammation in Alzheimer disease: driving force, bystander or beneficial response?

Wyss-Coray T.

Nat Med. 2006 Sep;12(9):1005-15. Review.

PMID:
16960575
[PubMed - indexed for MEDLINE]
19.

Not too excited? Thank your endocannabinoids.

Alger BE.

Neuron. 2006 Aug 17;51(4):393-5.

PMID:
16908404
[PubMed - indexed for MEDLINE]
Free Article
20.

Role for neuronal nitric-oxide synthase in cannabinoid-induced neurogenesis.

Kim SH, Won SJ, Mao XO, Ledent C, Jin K, Greenberg DA.

J Pharmacol Exp Ther. 2006 Oct;319(1):150-4. Epub 2006 Jul 10.

PMID:
16831955
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk